LXEO
Lexeo Therapeutics, Inc.
+0.10 (+2.40%)4.26USD675K成交股數350M市值–本益比(近四季)534.4股價營收比–營收年增(近四季)2026-11-04下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 19.0M | 15.7M | 15.7M | 14.7M | 17.2M | 18.4M | 23.4M | 16.6M | 15.7M | 17.2M | 11.2M | 16.4M |
| 銷售管理費用 | 9.0M | 6.6M | 6.0M | 16.0M | 16.6M | 9.0M | 8.1M | 7.0M | 7.5M | 3.0M | 2.7M | 2.9M |
| 營業利益 | −28.0M-17% | −22.3M-18% | −21.6M-31% | −30.7M+30% | −33.8M+45% | −27.4M+35% | −31.5M+126% | −23.6M+22% | −23.3M | −20.3M | −14.0M | −19.3M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −25.9M-21% | −20.2M-22% | −20.3M-31% | −26.1M+23% | −32.7M+51% | −25.9M+29% | −29.5M+119% | −21.2M+14% | −21.7M | −20.1M | −13.4M | −18.7M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.30-70% | -0.25-68% | -0.33-63% | -0.60-6% | -0.99+29% | -0.79-94% | -0.89-89% | -0.64-94% | -0.77 | -12.36 | -8.30 | -11.58 |
| 稀釋股數 | 85.6M | 81.2M | 61.0M | 43.6M | 33.1M | 31.8M | 33.1M | 33.0M | 28.0M | 1.6M | 1.6M | 1.6M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 92.8M | 71.8M | 41.0M | 35.5M | 28.9M | 35.0M | 157M | 175M | 195M | 35.4M | 48.8M | 62.1M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 255M | 250M | 144M | 176M | 126M | 147M | 174M | 192M | 213M | 54.7M | – | – |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 19.8M | 18.9M | 23.0M | 37.9M | 37.6M | 30.1M | 34.5M | 27.1M | 30.3M | 32.5M | – | – |
| 股東權益 | 235M | 231M | 121M | 138M | 88.1M | 117M | 139M | 165M | 183M | −163M | −144M | −131M |
| 負債比 | 7.8% | 7.5% | 16.0% | 21.5% | 29.9% | 20.5% | 19.9% | 14.1% | 14.2% | 59.4% | – | – |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −21.1M | – | – | −21.7M+46% | – | – | – | −14.9M | – | – | −18.4M |
| 資本支出 | – | 35K | – | – | – | – | – | – | 185K | – | – | – |
| 自由現金流 | – | −21.2M | – | – | – | – | – | – | −15.1M | – | – | – |
| 折舊攤銷 | – | 73K | – | – | 60K | – | – | – | 69K | – | – | 57K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −100M | –% | -1.86 | −99.0M |
| FY2024 | – | – | −98.3M | –% | -3.09 | −81.6M |
| FY2023 | – | – | −66.4M | –% | -12.40 | −59.6M |
| FY2022 | 654K | – | −59.3M | -9,063.8% | -36.36 | −55.2M |